2026 Maryland MedTech Summit

MedTech Innovations for Health Systems

Tuesday, March 24, 2026

Time: 10 a.m.-6:30 p.m.

Location: Stamp Student Union Grand Ballroom, University of Maryland, College Park

Join medical device innovators, investors, universities, and the rest of the capital health region, for a full-day event to celebrate and build our medtech industry. Come for panels, breakout sessions, networking and opportunities to present your business needs, as we explore the impact and future of medtech in the DMV region and beyond, opportunities to participate in federal and regional initiatives, device manufacturing, go-to-market strategies, and more.

The Maryland MedTech Summit is the cornerstone event of Maryland MedTech Week, taking place across the DMV March 23-27, 2026.

Tentative Agenda

9:30 a.m.

Registration and Coffee

10:00 a.m.

Welcome and Opening Remarks

10:15 a.m.

Morning Kickoff
Meena Seshamani, MD, Ph.D, Secretary of Health, Maryland Department of Health

10:30 a.m.

General Session 1
Innovation at Scale: Proving Value Across the Enterprise

11:15 a.m.

Coffee and Collaboration Break

11:25 a.m.

General Session 2
Built on the Frontlines: Bottom-Up Innovation in Health Systems

12:10 p.m.

General Session 3
Funding Your Innovation

12:55 p.m.

Networking Lunch + Collaboration Catalyst Quick Pitches

1:55 p.m.

Afternoon Kickoff
‍
‍Regulator: Friend or Foe to Innovation
Joshua Sharfstein, MD, Vice Dean for Public Health Practice and Community Engagement, Bloomberg American Health Initiative Director and Bloomberg Distinguished Professor of the Practice in American Health, Bloomberg School of Public Health, Johns Hopkins University

2:10 p.m.

Parallel Panel Session 1
Choose from one of two track options:

Track A: Building in Maryland: Advanced Manufacturing Pathways
Track B: Built in Maryland: MedTech Wins and What We Learned

2:55 p.m.

Coffee and Collaboration Break
Transition to breakout rooms

3:05 p.m.

Parallel Panel Session 2
Choose one of two track options:
‍
Track A: Data as a Clinical Asset: AI and Digital Health
Track B: Global Partners: Finding Your Footing in Maryland

3:50 p.m.

Coffee and Collaboration Break
Transition to breakout rooms

4:00 p.m.

Parallel Panel Session 3
Choose one of two track options:

‍Track A: Dual Use Technology: Leveraging Military Support for Innovation
Track B: The Brain State: Maryland’s Neurotech Breakthrough Era

4:45 p.m.

General Session 5
The Edge of Impact: The Next Era of Medical Innovation

5:30 p.m.

Happy Hour

William Bentley, Ph.D.

Professor and Director
University of Maryland

Therese Canares, MD, MBA

CEO, CurieDX

Dean Chang, Ph.D.

Chief Innovation Officer, University of Maryland

Nick Culbertson

Managing Director, Techstars AI Health Baltimore

Deanna Angello, MBA

Chief Commercial Officer, Cognito Therapeutics; Former Executive in Residence, Springboard Enterprises

Ibraheem Badejo, Ph.D., MLS

Senior R&D Director, External Front End Innovation, Johnson & Johnson

Norman J. Beauchamp, Jr., MD, MHS

Executive VP for Health Sciences and Executive Dean of the School of Medicine, Georgetown University Medical Center

Norman J. Beauchamp Jr., MD, MHS, serves as Executive Vice President for Health Sciences and Executive Dean of the School of Medicine. He is responsible for advancing the educational and research missions of Georgetown University Medical Center and working effectively with the leadership of MedStar Health, its academic health system partner, to fully align efforts in clinical care and improve human health with an emphasis on care of the whole person or cura personalis. He is a tenured faculty member in the Department of Neurology, with a secondary appointment in the Department of Radiology at Georgetown University School of Medicine.

From 2019 to 2024, Beauchamp served as Executive Vice President for Health Sciences at Michigan State University. From 2016 to 2019, he led the reorganization of the health colleges and the clinical practice at MSU into a unified health sciences structure to include the university’s clinical practice, osteopathic (DO) and allopathic (MD) medical colleges and the College of Nursing. In addition, Beauchamp also served as the co-architect, alongside leaders at Henry Ford Health, in establishing a 30-year partnership between MSU Health Sciences and Henry Ford Health. He served on the board of the Henry Ford Hospital. During MSU’s reorganization, Beauchamp held numerous roles including Dean, College of Human Medicine (2016-2019), Executive Dean of the Health Colleges (2018-2019), Assistant Vice President for Health Affairs (2018-2019) and Associate Provost for Health Affairs (2018-2024).

Beauchamp earned his medical degree at Michigan State University (MSU). He began his medical career at the School of Medicine at Johns Hopkins University, where he completed his radiology residency, neuroradiology fellowship, and neurointerventional training before joining their faculty in 1996. There, he served as vice chair for clinical operations and interim chair for radiology. He then moved to the University of Washington, where he spent 14 years as professor and chair of the Department of Radiology before joining MSU. During this time, he also served as President of the Clinical Practice Plan for the University of Washington School of Medicine and served on the University of Washington Medical Center Board. He led the Physician Engagement component of the Studer Initiative. He co-authored a proposal to the Bill and Melinda Gates Foundation that resulted in a campus-wide Institute for Population Health and was the founding medical director of the Seattle King County Free Clinic.

Beauchamp is a leading researcher in the diagnosis and treatment of stroke. As a neurointerventional radiologist, his research has focused on improving approaches to stroke prevention, diagnosis, and treatment. He has published more than 100 peer-reviewed papers. He is a fellow in the American College of Radiology and led the educational efforts for the ACR. He was President of the American Roentgen Ray Society and the Society of Chairs of Academic Radiology.

His academic appointments have also included being a scientist in applied physics and a professor of industrial engineering and systems design.

Justin Brooks, MD, Ph.D.

Director of Entrepreneurship, University of Maryland Institute for Health Computing

Chuck Callahan, DO

Professor of Pediatrics and Community Health, University of Maryland School of Medicine

Kathie Callahan Brady

President and CEO, Frederick Innovative Technology Center, Inc.

Alex Cameron

Global Vice President and Head Atellica Solutions, Siemens Healthineers

Nilanjan Chatterjee, Ph.D.

Bloomberg Distinguished Professor, Johns Hopkins University

Jesse Christopher

CEO and Co-Founder, Longeviti Neuro Solutions

Kelly Collier

Director of Ecosystem Development, LifeX

George Davis, MS

Fund Manager, Wexford SciTech Venture Fund

Ashwini Davison, MD

Chief Medical Informatics Officer, Oncology, Amazon Web Services

Jonathan Dayton, DrPH(c), MS, NREMT, CNE

Executive Director and CEO, Maryland Rural Health Association

Graham Dodge

VP of Venture Development, TEDCO

Linda Durnell, Ph.D.

Director of MedTech Strategies, Johns Hopkins University

Dan Edelstein

VP and General Manager, Haystack Oncology, Quest Diagnostics

Lauren Eskew

Director of Business Development, Key Tech, Inc.

John Gilstrap

Assistant Secretary, Division of Innovation and Growth, Maryland Department of Commerce

Elizabeth Good Mazhari

Investment & Ecosystem Advisor (Consultant), TEDCO

Katharine Goodman, JD, Ph.D.

Assistant Professor, Epidemiology & Public Health, University of Maryland School of Medicine

Paul Grand

CEO, MedTech Innovator

Deborah Heminigway, Ph.D.

Managing Partner, Ecphora Capital

Nicholas King

Executive Director, PSTC, Critical Path Institute

Stephen Kinsey, MS, MBA

Principal, Business Innovation Lab, MedStar Health, Inc.

Laura Koman, JD

Partner, Jones Day

Arun Krishna

VP, US Franchise Head, Lung Cancer, AstraZeneca

Abishek Kulshreshtha, Ph.D.

Executive Director, Maryland Innovation Initiative

Mary Morris

Director, Baltimore Fund, University of Maryland, Baltimore

Myra Norton

Senior Director Business Initiatives, Johns Hopkins Technology Ventures

Mike Ravenscroft, MBA

Managing Director, Maryland Momentum Fund

Christopher T. Steele, Ph.D.

Chief of Strategy, Medical Technology Enterprise Consortium (MTEC)

Bob Storey

Managing Partner, The LaunchPort

Martha Wang, Ph.D.

Assistant Director, Fischell Institute for Biomedical Devices

Sponsorship Opportunities

Sponsors of the 2026 Maryland MedTech Summit will be front and center at the State’s premiere medical device and health technology event. This event will anchor Maryland MedTech Week, March 23-27, 2026, created to convene, celebrate and grow Maryland’s MedTech community.

Become a sponsor today to gain access to more than 400 influential industry innovators, investors, researchers, university offices, and more, and support Maryland's MedTech community by making this event accessible at no cost to attendees.

View available sponsorship opportunities.

Interested in sponsoring? Contact Bradley Gillenwater at bradley.gillenwater1@maryland.gov for full details.

Catalyst Quick Pitch

Interested in getting on stage at the Maryland MedTech Summit on March 24, 2026 to share the collaboration you need to advance your MedTech startup or device? Apply to be a part of the Catalyst Quick Pitch!

If selected, you will have the opportunity to present 1 slide in 1-2 minutes to share what you are working towards and seek the collaboration you need to succeed. Please note that you are required to submit a draft slide as part of the application.

Those selected to participate will be contacted directly before or during the week of March 2-6, 2026. Applications will close when all slots are filled.

Apply now!